FIELD: chemistry.
SUBSTANCE: invention relates to a novel salt form of 5-[(2R,5S)-5-methyl-4-propylmorpholin-2-yl]piridine-2-amine (I): , and specifically to 5-[2R,5S)-5-methyl-4-propylmorpholin-2-yl]pyridine-2-amine di-(1S)-camphorsulphonate (di-S-camsylate), to a pharmaceutical composition having effect on dopamine D3 receptor, as well use of the given compound in preparing a medicinal agent for treating sexual dysfunction and neuropsychiatric disorders and a method of obtaining the said compound and an intermediate compound.
EFFECT: novel salt form of a dopamine agonist which has advantages, specifically is not hygroscopic, has a crystalline form and has high melting point is obtained and described.
11 cl, 9 ex, 2 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
1,2,4-TRIAZOLO[4,3-A]PYRIDINE COMPOUNDS AND USE THEREOF AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS | 2015 |
|
RU2695651C2 |
SEPARATION OF ENANTIOMERS OF 3-ETHYLBICYCLO [3_2_0] HEPT-3-EN-6-ONE | 2016 |
|
RU2734475C2 |
IMIDAZOPYRIDINE COMPOUNDS USEFUL IN TREATMENT OF CONDITION ASSOCIATED WITH P2X3 AND/OR P2X2/3 ACTIVITY | 2014 |
|
RU2656593C2 |
NEW COMPOUNDS | 2000 |
|
RU2258703C2 |
NEW 5,7-DISUBSTITUTED [1,3]THIAZOLO-[4,5-d]PYRIMIDIN-2(3H)-ONE DERIVATIVES AND THEIR APPLICATION IN THERAPY | 2007 |
|
RU2441012C2 |
DERIVATIVES OF 4-(PHENYLPIPERAZINYLMETHYL)-BENZAMIDE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2297412C2 |
ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
METHOD OF TREATMENT OF DISEASES AT MAMMALS | 2004 |
|
RU2344121C2 |
NOVEL 5,7-DISUBSTITUTED [1,3]THIAZOLO[4,5-d]PYRIMIDINE-2-(3H)-AMINE DERIVATIVES AND USE THEREOF IN THERAPY | 2007 |
|
RU2437889C2 |
PYRIDYL-PIPERIDINE ANTAGONISTS OF OREXIN RECEPTORS | 2008 |
|
RU2470021C2 |
Authors
Dates
2010-06-27—Published
2006-01-26—Filed